Close Menu

hereditary disease

The NYGC is currently preparing to submit a number of additional clinical tests to the state including assays for cancer and constitutional disorders.

The lab has also switched its gene panels from the Illumina HiSeq to the MiSeq platform.

The company has raised a total of $75 million in venture capital to date.

Using arrays and exome sequencing, the study aims to diagnoses children with previously undiagnosed developmental disorders.

Invitae has received accreditation for its laboratory from the College of American Pathologists as well as coverage eligibility from Blue Shield of California and the Centers for Medicare and Medicaid Services.

The American College of Medical Genetics & Genomics updated its recommendations for the analysis & reporting of secondary findings from clinical genome-scale sequencing & released results of a 2013 about its initial recommendations from 2013.

NEW YORK (GenomeWeb) — Though most disease-causing genes are expressed throughout the body, they typically have an effect in one tissue, and unraveling that effect can reveal the molecular ba

Maybe more important than the gene they discovered, which only explains a fraction of inherited pancreatic cancers, is the sequencing-based approach the researchers took to pinpoint it.

Pages

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.